Lipocine Inc. - Common Stock, par value $0.0001 per share (LPCN)

21 filings reported holding LPCN - Lipocine Inc. - Common Stock, par value $0.0001 per share as of Q1 2024.
Lipocine Inc. - Common Stock, par value $0.0001 per share (LPCN) has 17 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 473,865 shares of 5,555,556 outstanding shares and own 8.53% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (221,459 shares), BlackRock Inc. (74,522 shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (59,667 shares), GEODE CAPITAL MANAGEMENT, LLC (48,854 shares), TWO SIGMA ADVISERS, LP (25,722 shares), RENAISSANCE TECHNOLOGIES LLC (21,097 shares), STATE STREET CORP (18,626 shares), Tower Research Capital LLC (TRC) (2,014 shares), MORGAN STANLEY (722 shares), and CALDWELL SUTTER CAPITAL, INC. (471 shares).
This table shows the top 17 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.